Genomic and Epigenomic Biomarkers of Toxicology and Disease. Группа авторов
Чтение книги онлайн.

Читать онлайн книгу Genomic and Epigenomic Biomarkers of Toxicology and Disease - Группа авторов страница 9

Название: Genomic and Epigenomic Biomarkers of Toxicology and Disease

Автор: Группа авторов

Издательство: John Wiley & Sons Limited

Жанр: Химия

Серия:

isbn: 9781119807698

isbn:

СКАЧАТЬ style="font-size:15px;">      494  481

      495  482

      496  483

      497  484

      498  485

      499  486

       This book is dedicated to my family:

       My late parents, Gopinath and Ichhamoni, for their gift of life, love, and living examples

       My wife, Jharana, for her life-long friendship, love, and support as well as for her patience and understanding of the long hours I spent at home on planning, writing, and editing this book

       My children, Meghamala, Sudhir, Subir, and their spouses, for their love and care

       My granddaughter, Naomi, and my grandson, Jonah, for their unconditional love, faith, and trust in me

      Saura C. Sahu, PhD

      Columbia, MD

      August 2021

      A biomarker is a measurable substance, found in body fluids or tissues as a result of exposure, infection, and/or disease, and it can be used for clinical practice. Genomics and epigenomics are modern scientific developments of the twenty-first century. They regulate gene expressions and play important roles in a wide range of human diseases, including cancer. The microRNAs are an important component of the molecular mechanisms of disease processes. Therefore they demonstrate potential for serving as biomarkers.

      It is my sincere hope that the up-to-date information presented in this monograph will serve as a stimulus to investigators interested in genomic and epigenomic biomarkers research.

      The importance of research on genomic and epigenomic biomarkers is evidenced by the growing number of contributions published each year. It becomes increasingly clear that developments in this field are moving so rapidly that new means are needed to report the status of ongoing research activities. The contributions presented in this monograph represent a collaborative effort by international experts in this emerging field of science.

      The main purpose of this book is to assemble up-to-date, state-of-the-art information on genomic and epigenomic biomarkers presented by internationally recognized experts in a single edition. I sincerely hope that this book will provide an authoritative source of current information on biomarkers research and will prove useful to the scientists interested in this scientific discipline throughout the world. Moreover, it should be of interest to a variety of other scientific disciplines such as toxicology, medicine, and pharmacology, as well as to drug and food sciences.

       Saura C. Sahu, PhD

      Columbia, MD

      I am indebted to the internationally recognized experts who shared my enthusiasm for this field of science and contributed generously to this book. They were selected from academia, industry, and government for their expertise in their own areas of research. Their work speaks for itself, and I am grateful to them for their strong commitment, cooperation, and excellent contributions in their areas of expertise.

      I thank John Wiley & Sons Ltd, particularly Jenny Cossham and Katrina Maceda, for their excellent help, cooperation, support, and assistance with the timely publication of this book. Wiley published my first book, Hepatotoxicity: From Genomics to in vitro and in vivo Models, in 2007. Since then Wiley has published fifteen more of my books (including the current one), all in new, different, emerging, and developing areas of modern toxicology and medicine such as nanotoxicology, systems toxicology, toxicogenomics, epigenomics, microRNAs, stem cells—and I am still counting. I am amazed at Wiley’s trust in me. I am grateful to John Wiley & Sons Ltd for the rest of my life!

       Saura C. Sahu, PhD

      Columbia, MD

       Eid Alshammari

      Department of Biochemistry, Microbiology,

      and Immunology, Wayne State University

      School of Medicine, Detroit, MI, USA

       Mayukh Banerjee

      Department of Pharmacology and

      Toxicology, University of Louisville School

      of Medicine, Louisville, KY, USA

       Robert Y.S. Cheng

      Molecular Mechanisms Section, Cancer

      and Inflammation Program, Center

      for Cancer Research, National Cancer

      Institute, Frederick, MD, USA

       Brian N. Chorley

      Center for Computational Toxicology

      and Exposure, Office of Research and

      Development, U.S. Environmental

      Protection Agency, NC, USA

       Carmen Elena Condrat

      Carol Davila University of Medicine and

      Pharmacy, Bucharest, Romania;

      Alessandrescu-Rusescu National Institute

      for Mother and Child Health, Fetal

      Medicine Excellence Research Center,

      Bucharest, Romania

       Matei-Alexandru Cozma

      Department of Gastroenterology, Colentina

      Clinical Hospital, 20125 Bucharest,

      Romania

       Dragos Cretoiu

      Alessandrescu-Rusescu National Institute

      for Mother and Child Health, Fetal

      Medicine Excellence Research Center,

      020395 Bucharest, Romania;

      Department of Cell and Molecular Biology

      and Histology, Carol Davila University

      of Medicine and Pharmacy, Bucharest,

      Romania

СКАЧАТЬ